Skip to main navigation Skip to search Skip to main content

Antitumor activity of the Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels

  • Barbara A. Helfrich
  • , David Raben
  • , Marileila Varella-Garcia
  • , Dan Gustafson
  • , Daniel C. Chan
  • , Lynne Bemis
  • , Chris Coldren
  • , Anna Barón
  • , Chan Zeng
  • , Wilbur A. Franklin
  • , Fred R. Hirsch
  • , Adi Gazdar
  • , John Minna
  • , Paul A. Bunn

Research output: Contribution to journal › Article › peer-review

123   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Antitumor activity of the Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science